Skip to main content

Table 4 Correlation between tumor size and CT-based therapeutic response in the study population

From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma

 Therapeutic response by RECISTTest value#P valueSig.
CRPRSDPD
Base (sum)
 Median (IQR)35 (22.5–46.75)69.5 (47.5–95)35 (17–39.7)77.5 (33.75–136.5)7.8210.050S
 Range7.5–638.5–12517–39.73.5–182
End (sum)
 Median (IQR)0 (0–0)28.5 (6.2–36.5)29 (16.8–37)26.5 (13–61)16.7710.001HS
 Range0–01–7816.8–370–95
Tumor reduction (%)
 Median (IQR)100 (100–100)65.5 (52–76)6 (0.01–17)59 (47–70)22.2060.000HS
 Range100–10031–910.01–1747–70
  1. P value > 0.05 Non-significant (NS), P value < 0.05 Significant (S), P value < 0.01 Highly significant (HS)
  2. # Kruskal–Wallis test